Cell Therapies vs. Neurodegeneration by Cristina Stoyanov

A personal story and where I see breakthroughs making the leap from labs to lives.

The Scalability Signal: When Pharma Pounces by Cristina Stoyanov

Why platform technologies may be the scale engine biotech's been waiting for

Are Cell Therapies at an Inflection Point? by Cristina Stoyanov

Breakthroughs in Cell Therapy Are Accelerating — Here’s Where Investors Should Look Beyond the Hype